<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Optimizing Syngeneic Translatability through POC and Target Engagement Studies

While syngeneic tumor model use is widespread in preclinical immunotherapy drug development, there are concerns about the translatability of the models.